You are here

Article Text

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients
  1. Lihi Eder1,
  2. Vinod Chandran1,
  3. Fawnda Pellett1,
  4. Remy Pollock1,
  5. Sutha Shanmugarajah1,
  6. Cheryl F Rosen2,
  7. Proton Rahman3,
  8. Dafna D Gladman1
  1. 1Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Psoriatic Arthritis Clinic, Toronto Western Hospital, Toronto, Ontario, Canada
  2. 2Division of Dermatology, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada
  3. 3Deaprtment of Medicine, Memorial University of Newfoundland, St Clare's Mercy Hospital, St John's, Newfoundland, Canada
  1. Correspondence to Dr Dafna D Gladman, Centre for Prognosis Studies in the Rheumatic Diseases 1E-410B, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada; dafna.gladman{at}utoronto.ca

Abstract

Aim To study the association between smoking and IL13 gene polymorphisms with psoriatic arthritis (PsA) and psoriasis.

Methods The authors genotyped three groups of Caucasians: those with PsA, those with psoriasis without arthritis (PsC) and healthy controls for the rs20541 and rs848 IL13 single nucleotide polymorphisms (SNPs). An additional SNP, rs1800925, was genotyped only in the PsA and PsC groups. The differences in allelic distributions were compared by χ2 test. The prevalence of smoking was compared between people with PsA and those with PsC. The combined effect of genotype and smoking was tested by comparing the frequencies of different combinations of rs1800925 genotype and smoking status in PsA and PsC.

Results 555 PsA patients, 342 PsC patients and 217 healthy controls were included in the study. Smoking was less prevalent in patients with PsA compared with PsC (47.4% vs 59.4%, p<0.0006). rs20541*G and rs848*C alleles were associated with PsA compared with controls (OR 1.64, p=0.0005, OR 1.61, p=0.0007 respectively). The association between these alleles and PsC compared with controls was only of borderline significance (OR 1.33, p=0.06, OR 1.26, p=0.11 respectively). Two major alleles, rs1800925*C (OR 1.28, p=0.045) and rs848*C (OR 1.30, p=0.047) were increased in PsA compared with PsC. The combination of non-smoking and the genotype rs1800925*CC was associated with increased susceptibility to PsA compared with PsC. Among smokers, rs1800925*CC was not associated with PsA compared with PsC.

Conclusions IL13 gene polymorphism is associated with increased susceptibility to PsA in psoriasis patients.

https://doi.org/10.1136/ard.2010.147421

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding Krembil Foundation – Canada, The Arthritis Society – Canada, Canadian Arthritis Network, Canadian Institutes of Health Research.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval This study was conducted with the approval of the University Health Network (Toronto Western Hospital).

    • Provenance and peer review Not commissioned; externally peer reviewed.